Clinical Trial Update: Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and immunogenicity of a quadrivalent meningococcal vaccine given with routine pediatric vaccines in healthy infants and toddlers …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Meningococcal Infection

Drugs mentioned

• Quadrivalent meningococcal conjugate vaccine (meningococcal conjugate vaccine quadrivalent (MenACWY))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Healthy Volunteers (Meningococcal Infection) | Phase 3 | Status: COMPLETED | Results posted: 2023-10-19